AstraZeneca-Oxford University's Covishield vaccine and Bharat Biotech's Covaxin get approval for immunisation against Covid-19 in India 
Special 
AstraZeneca-Oxford University's Covishield vaccine and Bharat Biotech's Covaxin get approval for immunisation against Covid-19 in India Hailing the approval of two "Made in India" coronavirus vaccines, Prime Minister Narendra Modi congratulated the country's scientists, innovators, and countrymen.
The PM wrote, "It would make every Indian proud that the two vaccines that have been given emergency use approval are made in India!". He said the rapid manufacturing of the vaccines in the country is proof of the eagerness of scientists to fulfil the dream of Atmanirbhar Bharat.
It would make every Indian proud that the two vaccines that have been given emergency use approval are made in India! This shows the eagerness of our scientific community to fulfil the dream of an Aatmanirbhar Bharat, at the root of which is care and compassion.
Narendra Modi (@narendramodi) January 3, 2021
The prime minister also wrote, "A decisive turning point to strengthen a spirited fight! DCGI granting approval to vaccines of Serum Institute of India and Bharat Biotech accelerates the road to a healthier and COVID-free nation. Congratulations India. Congratulations to our hardworking scientists and innovators".
A decisive turning point to strengthen a spirited fight!
DCGI granting approval to vaccines of @SerumInstIndia and @BharatBiotech accelerates the road to a healthier and COVID-free nation.
Congratulations India.
Congratulations to our hardworking scientists and innovators.Narendra Modi (@narendramodi) January 3, 2021
PM Modi thanked doctors, medical staff, police personnel, sanitation workers and all corona warriors for their hard work during the coronavirus outbreak.
"We will remain eternally grateful to them for saving many lives," the Prime Minister said.
We reiterate our gratitude to doctors, medical staff, scientists, police personnel, sanitation workers and all Corona warriors for the outstanding work done, that too in adverse circumstances. We will remain eternally grateful to them for saving many lives.
Narendra Modi (@narendramodi) January 3, 2021
On Sunday, the Drugs Controller General of India (DCGI) gave its official nod to AstraZeneca-Oxford University's Covishield vaccine and Bharat Biotech's Covaxin for immunisation against Covid-19 in India.
The Serum Institute of India, the world's largest vaccine manufacturer, has tied up with Oxford-AstraZeneca to manufacture Covishield.
The approval by the DCGI was given on the basis of recommendations submitted by a COVID-19 subject expert committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO).
At this historic moment in India's medical history, SII Pune's CEO Adar Poonwalla also shared his happiness on Twitter. Poonwalla wrote, " Happy new year, everyone! All the risks @SerumInstIndia took with stockpiling the vaccine, have finally paid off. COVISHIELD, India's first COVID-19 vaccine is approved, safe, effective and ready to roll-out in the coming weeks".
Happy new year, everyone! All the risks @SerumInstIndia took with stockpiling the vaccine, have finally paid off. COVISHIELD, India's first COVID-19 vaccine is approved, safe, effective and ready to roll-out in the coming weeks. pic.twitter.com/TcKh4bZIKK
Adar Poonawalla (@adarpoonawalla) January 3, 2021
Also read: Four variants of coronavirus found since beginning of pandemic, says WHO
Copyright©2025 Living Media India Limited. For reprint rights: Syndications Today
